From: Limited benefit of repeating a sensitive question in a cross-sectional sexual health study
Ā | No change | Increase | Decrease | p-value* | |||
---|---|---|---|---|---|---|---|
Ā | n | (%) | n | (%) | n | (%) | Ā |
Total | 433 | (85.7%) | 54 | (10.7%) | 18 | (3.6%) | Ā |
Sex | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āāMale | 209 | (83.6%) | 28 | (11.2%) | 13 | (5.2%) | 0.124 |
āāFemale | 224 | (87.8%) | 26 | (10.2%) | 5 | (2.0%) | |
Mode | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āāSelf-administered | 345 | (83.5%) | 50 | (12.1%) | 18 | (4.4%) | 0.006 |
āāRA-administered | 78 | (96.3%) | 3 | (3.7%) | 0 | (0.0%) | |
āāMissing | 11 | (90.9%) | 1 | (9.1%) | 0 | (0.0%) | Ā |
HSV-2 status | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āāHSV-2 negative | 158 | (88.8%) | 14 | (7.9%) | 6 | (3.4%) | 0.073 |
āāHSV-2 positive | 188 | (81.0%) | 35 | (15.1%) | 9 | (3.9%) | |
āāMissing | 87 | (91.6%) | 5 | (5.3%) | 3 | (3.2%) | Ā |
Age (years) | Ā | Ā | Ā | Ā | Ā | Ā | Ā |
āā14-21 | 38 | (77.6%) | 7 | (14.3%) | 4 | (8.2%) | 0.428 |
āā22-29 | 134 | (87.6%) | 12 | (7.8%) | 7 | (4.6%) | |
āā30-37 | 135 | (87.1%) | 18 | (11.6%) | 2 | (1.3%) | |
āā38-45 | 74 | (85.1%) | 10 | (11.5%) | 3 | (3.4%) | |
āā46+ | 40 | (83.3%) | 6 | (12.5%) | 2 | (4.2%) | |
āāMissing | 12 | (92.3%) | 1 | (7.7%) | 0 | (0.0%) | Ā |